• 2010 April 04

Company Description

TranquilMed develops drugs and treatments with a focus on patients suffering with restless legs syndrome.

We have a new treatment for those suffering with Restless Legs Syndrome (RLS). 30 million people in the U.S. suffer discomfort and sleep loss due to Restless Legs Syndrome (RLS). Sufferers spend $1.5B for relatively ineffective treatments that produce side effects of nausea and vomiting. These treatments lose effectiveness over time and can make the condition worse. TranquilMedâ€s new product RestEasyâ„¢ is the first treatment with no side effects available to RLS sufferers. We have conducted studies at BYU that show 52% reduction in RLS symptoms in only 12 treatments. These studies have been accepted for publication in peer reviewed medical journals.